Quiero saber acerca de...

Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Center for Complementary &
Integrative Health; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel; NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception 2.
Date: March 18th, 2021.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Complementary and Integrative Health, Dem II, 6707
Democracy Blvd., Bethesda, MD 20892
Virtual Meeting.
Contact Person: Martina Schmidt, Ph.D., Chief Office of Scientific Review, National Center for Complementary & Integrative Health, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, 3015943456, schmidma@mail.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS
Dated: January 27, 2021.
Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202102299 Filed 2321; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

jbell on DSKJLSW7X2PROD with NOTICES

National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
VerDate Sep<11>2014

17:13 Feb 03, 2021

Jkt 253001

provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Collaborative Cross Mouse Model Generation and Discovery of Immunoregulatory Mechanisms R21.
Date: February 25, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G41, Rockville, MD 20892 Virtual Meeting.
Contact Person: Tara Capece, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G41, Rockville, MD
20852, 2401914281, capecet2@
niaid.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS
Dated: January 28, 2021.
Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202102303 Filed 2321; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

PO 00000

Frm 00050

Fmt 4703

Sfmt 9990

8209

Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; CTSA Collaborative Innovation Awards Review Meeting.
Date: February 17, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1073, Bethesda, MD 20892 Virtual Meeting.
Contact Person: M. Lourdes Ponce, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1073, Bethesda, MD 20892, 3014350810, lourdes.ponce@nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, BCooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS
Dated: January 22, 2021.
David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202102280 Filed 2321; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Amended Notice of Meetings Notice is hereby given of a change in the meetings of the National Institute of Child Health and Human Development Special Emphasis Panels, April 20, 2021, 8:00 a.m. to April 21, 2021, 6:00
p.m., NIH, and April 22, 2021, 8:00 a.m.
to April 22, 2021, 6:00 p.m., NIH, 6710B
Rockledge Drive, Bethesda, MD 20892
which was published in the Federal Register on January 15, 2021, 86 FR
4105.
The dates of the meetings changed to March 9, 2021, 8:00 a.m. to March 10, 2021, 6:00 p.m. and March 11, 2021, 8:00 a.m. to March 11, 2021, 6:00 p.m., respectively.
The meetings are closed to the public.
Dated: January 29, 2021.
Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202102293 Filed 2321; 8:45 am BILLING CODE 414001P

E:FRFM04FEN1.SGM

04FEN1